What are the effects of long-term muscle relaxer use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Long-Term Muscle Relaxer Use: Effects and Risks

Long-term muscle relaxer use is not recommended due to significant risks including sedation, dependence, and potential for abuse, with limited evidence supporting efficacy beyond short-term use (2-3 weeks). 1, 2

Mechanism and Intended Use

Muscle relaxants represent a diverse group of medications with varying mechanisms of action:

  • They are FDA-approved only for short-term relief (2-3 weeks) of acute, painful musculoskeletal conditions 2
  • Their effects are primarily non-specific and not directly related to muscle relaxation 3
  • They may inhibit polysynaptic myogenic reflexes, but the relationship to pain relief remains unclear 3

Adverse Effects of Long-Term Use

Central Nervous System Effects

  • Sedation (primary concern) 3
  • Dizziness 3
  • Increased risk of falls, particularly in older adults 3, 1

Dependence and Abuse Potential

  • Risk for physical and psychological dependence 4, 5
  • Potential for misuse, particularly with carisoprodol 4
  • Some have been removed from European markets due to abuse concerns (e.g., carisoprodol) 3

Specific Drug Concerns

  • Cyclobenzaprine: Anticholinergic effects (dry mouth), structurally similar to tricyclic antidepressants 3, 4
  • Carisoprodol: Metabolized to meprobamate (associated with abuse and overdose) 3
  • Dantrolene: Black box warning for potentially fatal hepatotoxicity 3
  • Tizanidine and chlorzoxazone: Associated with hepatotoxicity (usually reversible) 3

Efficacy for Chronic Pain Conditions

Recent systematic review evidence shows:

  • Not beneficial for long-term use in:

    • Low back pain
    • Fibromyalgia
    • Headaches 6
  • Potentially beneficial for long-term use in:

    • Painful spasms or cramps
    • Neck pain
    • Trigeminal neuralgia 6

Guidelines for Use

  1. Duration: Limited to short periods only (2-3 weeks maximum) 3, 2

    • Adequate evidence for effectiveness in longer periods is not available 2
    • Muscle spasm associated with acute conditions is generally short-duration 2
  2. Patient Selection:

    • Avoid in older adults when possible due to increased risk of falls 3, 1
    • Contraindicated in significant liver/kidney disease 1
    • Use with caution in patients with history of substance abuse 5
  3. Monitoring:

    • Watch for sedation, dry mouth, and dizziness 1
    • Advise patients to avoid activities requiring mental alertness 1
    • Be vigilant for signs of dependence or misuse 4, 5

Alternative Approaches

For chronic pain conditions requiring longer management:

  • Consider baclofen for spasticity from central nervous system injury or demyelinating conditions 3
  • For neuropathic pain components, consider anticonvulsants (gabapentin, pregabalin) 1
  • For central sensitization, consider tricyclic antidepressants or SNRIs 1
  • Physical therapy and non-pharmacological approaches should be prioritized 1

Key Pitfalls to Avoid

  1. Prescribing under false assumptions:

    • Muscle relaxants do not directly relax muscles despite their name 3
    • They should not be prescribed in the mistaken belief they relieve muscle spasm 3
  2. Dangerous combinations:

    • Avoid co-prescribing with benzodiazepines (increased respiratory depression risk) 1
    • Use caution when combining with other CNS depressants 5
  3. Inappropriate continuation:

    • Continuing beyond 2-3 weeks without clear evidence of benefit 2
    • Failing to deprescribe when pain-related goals are not met 6

References

Guideline

Renal Effects of Medications and Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A review of three commonly prescribed skeletal muscle relaxants.

Journal of back and musculoskeletal rehabilitation, 2000

Research

Abuse of skeletal muscle relaxants.

American family physician, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.